Opdivo is a programmed death receptor-1 (PD-1)-blocking antibody. It works to treat cancer by blocking a protein called PD-1 on immune cells, allowing them to better recognize and attack cancer cells. Opdivo is FDA approved to treat: Melanoma Non-small cell lung cancer Malignant pleural mes...
Is Opdivo a chemotherapy or immunotherapy drug? How are Opdivo and Yervoy administered? Is Opdivo approved for treating bladder cancer? Is Xalkori the same as Opdivo or Keytruda? What are biologic drugs and how do they work? Drug information ...
Many of the recent advances in immuno-oncology have involved checkpoint inhibitors, including the breakthrough PD-1 inhibitors pembrolizumab (Keytruda®) and nivolumab (Opdivo), as well as PD-L1 and CTLA-4 inhibitors. This antibody-based therapy binds to immune-checkpoint proteins expressed on...